- Report
- September 2021
- 111 Pages
Global
From €4031EUR$4,500USD£3,436GBP
- Report
- May 2024
- 160 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- February 2024
- 140 Pages
Global
From €4451EUR$4,969USD£3,794GBP
- Report
- May 2024
- 200 Pages
Global
From €3717EUR$4,150USD£3,169GBP
- Report
- October 2023
- 145 Pages
Global
From €2821EUR$3,150USD£2,405GBP
- Report
- October 2023
- 145 Pages
Global
From €2821EUR$3,150USD£2,405GBP
- Report
- May 2023
- 160 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- April 2023
- 147 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- April 2023
- 147 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- April 2023
- 147 Pages
Global
From €4433EUR$4,949USD£3,779GBP
- Report
- November 2023
- 30 Pages
Global
From €2911EUR$3,250USD£2,481GBP
- Report
- April 2023
- 180 Pages
Global
From €2687EUR$3,000USD£2,291GBP
- Report
- February 2022
- 210 Pages
Global
From €6718EUR$7,500USD£5,726GBP
- Report
- March 2024
- 150 Pages
Global
From €3986EUR$4,450USD£3,398GBP
- Drug Pipelines
- April 2024
- 202 Pages
Global
From €7121EUR$7,950USD£6,070GBP
- Report
- February 2024
- 30 Pages
United States
€2015EUR$2,250USD£1,718GBP
- Report
- May 2023
- 450 Pages
Global
From €4478EUR$5,000USD£3,818GBP
- Report
- April 2023
- 137 Pages
Global
From €6718EUR$7,500USD£5,726GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2463EUR$2,750USD£2,100GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2463EUR$2,750USD£2,100GBP

The Anti Tumour Necrosis Factor (anti-TNF) market is a subset of the Immune Disorders Drugs market. Anti-TNF drugs are used to treat a variety of immune-mediated diseases, such as rheumatoid arthritis, psoriasis, Crohn's disease, and ulcerative colitis. These drugs work by blocking the action of TNF, a protein that is involved in inflammation and tissue destruction. Anti-TNF drugs are generally administered as injections or infusions, and are often used in combination with other medications.
The anti-TNF market is highly competitive, with a number of companies offering products. These include AbbVie, Amgen, Janssen, Merck, Pfizer, and UCB. Each company has its own portfolio of anti-TNF drugs, and they are continually developing new products to meet the needs of patients. Show Less Read more